A Phase 2 Study of Zelquistinel or Placebo for the Reduction of Symptoms of Major Depressive Disorder

Clinical trial NCT07115329 · RECRUITING

Trial details

NCT number: NCT07115329
Sponsor: Syndeio Biosciences, Inc
Status: RECRUITING
Phase: Phase 2
Study type: INTERVENTIONAL

Major Depressive Disorder

Start date: 2026-01-05
Primary completion: 2028-03-30
Enrollment: 164

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.